FDA Finalizes Board Member Conflict Of Interest Policies

Aiming to shore up its conflict of interest policies, the U.S. Food and Drug Administration on Monday finalized policies for publicly disclosing the financial ties of advisory board members whose votes...

Already a subscriber? Click here to view full article